G. D. QURESHI, M.D.; THOMAS P. REINDERS, Pharm.D.; G. J. SOMORI, M.D.; HERBERT J. EVANS, Ph.D
Grant support: in part by General Clinical Research Center Grant no. RR00065.
▸Requests for reprints should be addressed to G.D. Qureshi, M.D.; Department of Medicine, Medical College of Virginia, Box 297, MCV Station; Richmond, VA 23298.
QURESHI GD, REINDERS TP, SOMORI GJ, EVANS HJ. Warfarin Resistance with Nafcillin Therapy. Ann Intern Med. 1984;100:527-529. doi: 10.7326/0003-4819-100-4-527
Download citation file:
Published: Ann Intern Med. 1984;100(4):527-529.
Drug-induced warfarin resistance may be mediated by the direct effect of a drug on warfarin's absorption, excretion, distribution, or metabolism. A 29-year-old man on long-term stable anticoagulation therapy with warfarin sodium developed resistance to warfarin while receiving nafcillin. His prothrombin time ranged between 14 and 17 s (control, 12 s) despite an increase in his warfarin dosage to 25 mg/d. Pharmacokinetic studies showed that the decreased hypoprothrombinemic effect of warfarin was most likely due to rapid metabolism of the anticoagulant induced by nafcillin. Warfarin's half-life was 11 hours when the patient was on nafcillin therapy and 44 hours when he was off nafcillin therapy. This interaction may be clinically important in patients requiring concomitant administration of nafcillin and warfarin.
Learn more about subscription options.
Register Now for a free account.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only